Glass House Brands (GLAS) Shares Outstanding (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Shares Outstanding (Entity) of $8.5 million for Q1 2026, up 7.37% year-over-year from $7.9 million in Q1 2025, and up 6.33% quarter-over-quarter from $8.0 million in Q4 2025.
Glass House Brands (GLAS) Shares Outstanding (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Shares Outstanding (Entity) for 7 consecutive years, with $8.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 7.37% year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $8.5 million (up 7.37% YoY), while the FY2025 annual figure was $8.0 million, up 8.92% from the prior year.
- Shares Outstanding (Entity) grew to $8.5 million in Q1 2026 per GLAS's latest filing, from $8.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $8.5 million in Q1 2026 and bottomed at $5.6 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $7.1 million across 5 years, with a median of $7.1 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 140.77% — and 2024, when it advanced 0.96%.
- Glass House Brands' Shares Outstanding (Entity) stood at $6.2 million in 2022, then increased by 12.23% to $7.0 million in 2023, then climbed by 4.44% to $7.3 million in 2024, then advanced by 8.92% to $8.0 million in 2025, then rose by 6.33% to $8.5 million in 2026.
- Business Quant data shows GLAS's Shares Outstanding (Entity) at $8.5 million in Q1 2026, $8.0 million in Q4 2025, and $8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 832.44 Mn |
| 10 | Glass House Brands | 829.33 Mn | 810.78 Mn | 15.77 Mn | 87.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.12 Mn |
| Dec 31, 2025 | 81.94 Mn |
| Sep 30, 2025 | 82.61 Mn |
| Jun 30, 2025 | 81.10 Mn |
| Mar 31, 2025 | 81.14 Mn |
| Dec 31, 2024 | 75.23 Mn |
| Sep 30, 2024 | 75.96 Mn |
| Jun 30, 2024 | 73.81 Mn |
| Mar 31, 2024 | 73.16 Mn |
| Dec 31, 2023 | 72.03 Mn |
| Sep 30, 2023 | 72.22 Mn |
| Jun 30, 2023 | 71.09 Mn |
| Mar 31, 2023 | 72.46 Mn |
| Dec 31, 2022 | 64.18 Mn |
| Sep 30, 2022 | 61.65 Mn |
| Jun 30, 2022 | 58.07 Mn |
| Mar 31, 2022 | 57.20 Mn |
| Dec 31, 2021 | 39.24 Mn |
| Sep 30, 2021 | 51.29 Mn |
| Jun 30, 2021 | 24.12 Mn |